Healthcare AI company Innovaccer closed a $275 million Series F funding round, bringing its fundraising total to date to $675 ...

Metabolic medicines dominated life sciences headlines in 2024, a trend expected to continue into the new year. Other things ...

Multiple reports indicate that employers can expect rising healthcare costs in 2025. To address these costs, employers are ...

In a new letter, 344 organizations urged the new Congress — which was sworn in on Jan. 3 — to protect and strengthen Medicaid ...

Healthcare organizations and health systems depend on accurate patient access data to inform their strategies, from managing no-show rates and appointment confirmations to optimizing payment ...

As startups transition from initial proof-of-concept technology to a commercially viable product, they will have to face and navigate the “Death Valley” curve. This critical phase, marked by a ...

Obstructive sleep apnea (OSA) is a serious, chronic sleep-related breathing disease that impacts an estimated 80 million people in the United States and nearly 1 billion globally. Untreated OSA ...

The Affordable Care Act's enhanced subsidies are at risk of expiring at the end of 2025, and healthcare leaders are worried about what could happen if Congress doesn’t renew them. For instance, more ...

Overcoming the systemic, structural and cultural issues that lead to poor nutrition is complex, making it even more essential ...

The pandemic shone a spotlight on the healthcare sector’s workforce issues, but the issue is far from resolved. The physician burnout rate may have dropped to below 50% last year — but many ...

Peptide drugs, such as the metabolic medicines Mounjaro and Zepbound from Eli Lilly, must be administered as injections. But the biotech industry has been pursuing ways to make peptides into pills ...